GlassScriptPhysician profile
Joseph M Schuster
NPI 1275829046
$221.12
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $30.71 · 2021: $57.19 · 2022: $83.98 · 2024: $49.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $49.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $49.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $63.80 | 2022 | |
| Galderma Laboratories, L.P. | $49.24 | 2024 | |
| Pfizer INC. | $29.50 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $24.17 | 2021 | |
| Alexion Pharmaceuticals, INC. | $20.18 | 2022 | |
| Vapotherm INC | $18.78 | 2021 | |
| Grifols USA, LLC | $15.45 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Schuster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.